Published in Transplant Proc on December 01, 1973
Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest (1976) 2.84
Genetic analysis of patients with chronic active hepatitis. J Clin Invest (1975) 0.97
Analysis of HLA-D micropolymorphism by a simple procedure: RNA oligonucleotide hybridization. J Clin Invest (1987) 0.82
Genetic aspects of canine mixed leukocyte cultures. J Exp Med (1974) 0.79
Evidence for transcriptional regulation of orotidine-5'-phosphate decarboxylase in yeast by hybridization of mRNA to the yeast structural gene cloned in Escherichia coli. Proc Natl Acad Sci U S A (1979) 6.81
Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43
Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature (1976) 4.83
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol (1989) 4.29
Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science (1973) 3.04
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Y-antigen killing by T cells of women is restricted by HLA. Nature (1977) 2.73
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity (1997) 2.45
HLA-linked genetic control of host response to Mycobacterium leprae. Lancet (1976) 2.45
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science (1988) 2.28
Direct selective techniques for the isolation of pyrimidine auxotrophs in yeast. Mol Gen Genet (1972) 2.28
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (1998) 2.11
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science (1975) 1.91
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
HLA-DW3 associated with coeliac disease. Lancet (1976) 1.79
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (1992) 1.76
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol (1999) 1.68
The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother (1980) 1.68
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens (1975) 1.54
Possible implications of the effect of blood transfusion on allograft survival. Lancet (1983) 1.46
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. Nat New Biol (1973) 1.44
In vitro immune responsiveness to vaccinea virus and HLA. N Engl J Med (1977) 1.43
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med (1989) 1.43
Appropriate and necessary healthcare: new language for a new era. Am J Manag Care (1997) 1.42
Early recurrent miscarriage: histology of conception products. Br J Obstet Gynaecol (1990) 1.42
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature (1978) 1.41
Biosynthesis of dipicolinic acid in sporulating Bacillus megaterium. J Biol Chem (1966) 1.40
Anti HL-A2 inhibitor in normal human serum. Nature (1970) 1.40
Immunoglobulin inclusions in non-Hodgkin's lymphomas. Am J Clin Pathol (1978) 1.40
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol (1999) 1.38
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet (1977) 1.37
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature (1983) 1.34
Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. Ann Rheum Dis (1984) 1.33
Mixed lymphocyte culture and HL-A. Transplant Proc (1972) 1.33
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30
Genetic control of survival in epidemics. J Immunogenet (1979) 1.28
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
The HL-A system. I. Genetics and molecular biology. Semin Hematol (1974) 1.26
Typing for MLC (LD). II. The selection of nonstimulator cells by MLC inhibition tests using SD-indentical stimulator cells (MISIS) and fluorescence antibody studies. Transplant Proc (1973) 1.26
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Efficacy of HL-A matching in Eurotransplant. Lancet (1972) 1.25
Do morphological anomalies reflect chromosomal aneuploidies?: case report. Hum Reprod (2000) 1.25
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer (1987) 1.25
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
Genetic control of mixed leukocyte culture reactivity. Transplant Rev (1972) 1.21
Abrogation of cytotoxicity of mixed leukocyte cultures. Transplant Proc (1972) 1.21
Alloimmunity to human H-Y. Lancet (1976) 1.20
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens (1998) 1.18
Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. N Engl J Med (1982) 1.18
Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol (1990) 1.15
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Platelet and granulocyte specific allo-antigens in chimpanzees. Tissue Antigens (1983) 1.14
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Letter: HL-A 27 and ankylosing spondylitis. Lancet (1975) 1.13
Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol (1995) 1.12
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11
Anti-self HLA may be clonally expressed. J Exp Med (1979) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A. Transplant Proc (1973) 1.09
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood (1994) 1.08
Mixed leukocyte cultures and immune response region disparity. Transplant Proc (1973) 1.08